DD DuPont
Q1 2025 10-Q
Filed: May 2, 2025Period ending Mar 31, 2025
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR DuPont (DD) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 2, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ1 2025 10-Q
Management Discussion & Analysis
- • Cash and equivalents $1.76B Mar 31, 2025 vs $1.85B Dec 31, 2024, total debt $7.17B stable
- • Operating cash flow $382M Q1 2025 vs $493M Q1 2024, decline primarily due to working capital and separation costs
Risk Factors
- • New trade disputes risk triggered by recent U.S. tariffs on imports from Canada, Mexico, China affecting supply chain and sales competitiveness
- • Materially updated risk: increased tariffs' uncertain duration and impact on sales, sourcing, and global operations centered on U.S.-China relations
Quarterly Financial SummaryXBRL
Revenue
$3.1B
▲ +4.6% YoY
Net Income
-$589M
▼ -411.6% YoY
Net Margin
-19.2%
▼ -2566bp YoY
EPS (Diluted)
$-1.41
▼ -413.3% YoY
Operating Cash Flow
$382M
▼ -22.5% YoY
Source: XBRL data from DuPont Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other DuPont Quarterly Reports
Get deeper insights on DuPont
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.